CEL-SCI Corp. (CVM: News ), Tuesday said an analysis of data from four mid-stage studies to evaluate safety and efficacy of its lead cancer drug Multikine,...(
read more)
Rexahn Pharmaceuticals, Inc. (AMEX:RNN) surged by 6.09% to close at $1.22 with overall traded volume of 1.40 million shares in the last trading day. The current market price is 11.43%...(
read more)
CEL-SCI Corporation (CVM) announced today that it has received a $733,437 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to three of the Company's projects, including the Phase III...(
read more)